CPHI Worldwide

Neuland Launches Peptide Manufacturing Module

The first module adds 7,000 liters of reactor capacity as Neuland prepares to accelerate a second phase of expansion.

CPHI Worldwide

Shilpa Biologicals, SPIMACO Bio Ink MENA Biosimilars Deal

Agreement covers PD-1 inhibitor biosimilars across Saudi Arabia and the wider MENA region.

CPHI Worldwide

Complex-Molecule Specialist Shilpa CDMO Launches at CPHI Milan

CDMO aims to accelerate timelines with end-to-end services for complex small-molecules.

CPHI Worldwide

SK pharmteco, Lotte Biologics Partner to Strengthen Global ADC CDMO Capabilities

Will deliver integrated, one-stop CDMO services spanning antibody drug substance, linker–payload production, and bioconjugation.

CPHI Worldwide

Lifecore Selected as Commercial Mfg. Partner for Leading Injectable Product

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.